Regulatory T Cells in Bioactive Peptides-Induced Oral Tolerance; a Two-Edged Sword Related to the Risk of Chronic Diseases: A Systematic Review

References

• Chalamaiah M, Keskin Ulug S, Hong H, Wu J. Regulatory requirements of bioactive peptides (protein hydrolysates) from food proteins. J Funct Foods. 2019;58:123–129. doi:10.1016/j.jff.2019.04.050
   Web of Science ®Google Scholar
• Chakrabarti S, Guha S, Majumder K. Food-derived bioactive peptides in human health: challenges and opportunities. Nutrients. 2018;10(11):1738. doi:10.3390/nu10111738
   PubMed Web of Science ®Google Scholar
• Díaz-Gómez JL, Castorena-Torres F, Preciado-Ortiz RE, García-Lara S. Anti-cancer activity of maize bioactive peptides. Front Chem. 2017;5:44. doi:10.3389/fchem.2017.00044
   PubMed Web of Science ®Google Scholar
• Aluko RE. Antihypertensive peptides from food proteins. Annu Rev Food Sci Technol. 2015;6:235–262. doi:10.1146/annurev-food-022814-015520
   PubMed Web of Science ®Google Scholar
• Mohanty D, Jena R, Choudhury PK, Pattnaik R, Mohapatra S, Saini MR. Milk derived antimicrobial bioactive peptides: a review. Int J Food Prop. 2016;19(4):837–846. doi:10.1080/10942912.2015.1048356
   Web of Science ®Google Scholar
• Bhat ZF, Kumar S, Bhat HF. Bioactive peptides of animal origin: a review. J Food Sci Technol. 2015;52(9):5377–5392. doi:10.1007/s13197-015-1731-5
   PubMed Web of Science ®Google Scholar
• González-Montoya M, Hernández-Ledesma B, Mora-Escobedo R, Martínez-Villaluenga C. Bioactive peptides from germinated soybean with anti-diabetic potential by inhibition of dipeptidyl peptidase-IV, α-amylase, and α-glucosidase enzymes. Int J Mol Sci. 2018;19(10):2883. doi:10.3390/ijms19102883
   PubMed Web of Science ®Google Scholar
• Moronta J, Smaldini PL, Fossati CA, Añon MC, Docena GH. The anti-inflammatory SSEDIKE peptide from Amaranth seeds modulates IgE-mediated food allergy. J Funct Foods. 2016;25:579–587. doi:10.1016/j.jff.2016.06.031
   Web of Science ®Google Scholar
• Jiménez M, Cervantes-García D, Muñoz YH, García A, Haro LM, Salinas E. Jr. Novel mechanisms underlying the therapeutic effect of glycomacropeptide on allergy: change in gut microbiota, upregulation of TGF-β, and inhibition of mast cells. Int Arch Allergy Immunol. 2016;171(3-4):217–226. doi:10.1159/000453035
   PubMed Web of Science ®Google Scholar
• Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol. 2012;5(3):232–239. doi:10.1038/mi.2012.4
   PubMed Web of Science ®Google Scholar
• Commins SP. Mechanisms of oral tolerance. Pediatr Clin North Am. 2015;62(6):1523–1529. doi:10.1016/j.pcl.2015.07.013
   PubMed Web of Science ®Google Scholar
• Husby S. Normal immune responses to ingested foods. J Pediatr Gastroenterol Nutr. 2000;30(Suppl):S13–S19. doi:10.1097/00005176-200001001-00003
   PubMed Web of Science ®Google Scholar
• Li Z, Luo Y, Feng L, Liao P. Effect of Maillard reaction conditions on antigenicity of β-lactoglobulin and the properties of glycated whey protein during simulated gastric digestion. Food Agric Immunol. 2013;24(4):433–443. doi:10.1080/09540105.2012.712951
   Web of Science ®Google Scholar
• Mundkur L, Mukhopadhyay R, Samson S, Varma M, Kale D, Chen D, Shivaprasad S, Sivanandan H, Soman V, Lu X, et al. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice. PLoS One. 2013;8(3):e58364. doi:10.1371/journal.pone.0058364
   PubMed Web of Science ®Google Scholar
• Nishikimi A, Koyama Y-I, Ishihara S, Kobayashi S, Tometsuka C, Kusubata M, Kuwaba K, Hayashida O, Hattori S, Katagiri K, et al. Collagen-derived peptides modulate CD4+ T-cell differentiation and suppress allergic responses in mice. Immun Inflamm Dis. 2018;6(2):245–255. doi:10.1002/iid3.213
   PubMed Web of Science ®Google Scholar
• Thota LN, Ponnusamy T, Philip S, Lu X, Mundkur L. Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apobtm2Sgy/Ldlrtm1Her/J mice. Sci Rep. 2017;7(1):3997–3997. doi:10.1038/s41598-017-04183-w
   PubMed Web of Science ®Google Scholar
• Barth SD, Schulze JJ, Kuhn T, Raschke E, Husing A, et al. Treg-mediated immune tolerance and the risk of solid cancers: findings from EPIC-Heidelberg. J Natl Cancer Inst. 2015;107(11):p.djv224. doi:10.1093/jnci/djv224
   PubMedGoogle Scholar
• Sidaway P. Risk factors: immune tolerance confers cancer risk. Nat Rev Clin Oncol. 2015;12(10):564. doi:10.1038/nrclinonc.2015.157
   PubMedGoogle Scholar
• Udenigwe CC, Fogliano V. Food matrix interaction and bioavailability of bioactive peptides: two faces of the same coin? J Funct Foods. 2017;35:9–12. doi:10.1016/j.jff.2017.05.029
   Web of Science ®Google Scholar
• Steele L, Mayer L, Berin MC. Mucosal immunology of tolerance and allergy in the gastrointestinal tract. Immunol Res. 2012;54(1-3):75–82. doi:10.1007/s12026-012-8308-4
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43. doi:10.1186/1471-2288-14-43
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928:doi:10.1136/bmj.d5928
   PubMed Web of Science ®Google Scholar
• Margulis AV, Pladevall M, Riera-Guardia N, Varas-Lorenzo C, Hazell L, Berkman ND, Viswanathan M, Perez-Gutthann S. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank. Clin Epidemiol. 2014;6:359–368. doi:10.2147/clep.s66677
   PubMed Web of Science ®Google Scholar
• Popay J, Roberts H, Sowden A, Petticrew M, Arai L, et al. Guidance on the conduct of narrative synthesis in systematic reviews. 2006. Guidance on the conduct of narrative synthesisin systematic reviews. A Product from the ESRC Methods ProgrammeVersion, 1, b92.
   Google Scholar
• Jimenez M, Chavez NA, Salinas E. Pretreatment with glycomacropeptide reduces allergen sensitization, alleviates immediate cutaneous hypersensitivity and protects from anaphylaxis. Clin Exp Immunol. 2012;170(1):18–27. doi:10.1111/j.1365-2249.2012.04631.x
   PubMed Web of Science ®Google Scholar
• He C, Song C-H, Cheng L, Chen T, Liu C, Liu Z, Yang P-C. Measles virus-derived peptide/food antigen adducts facilitate the establishment of antigen specific oral tolerance. J Physiol Pharmacol. 2013;64(1):95–102.
   PubMed Web of Science ®Google Scholar
• Roldan NR, Jimenez M, Cervantes-Garcia D, Marin E, Salinas E. Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat. Inflamm Res. 2016;65(4):273–283. doi:10.1007/s00011-015-0913-y
   PubMed Web of Science ®Google Scholar
• Xi C, Tan L, Sun Y, Liang F, Liu N, Xue H, Luo Y, Yuan F, Sun Y, Xi Y, et al. A novel recombinant peptide containing only two T-cell tolerance epitopes of chicken type II collagen that suppresses collagen-induced arthritis. Mol Immunol. 2009;46(4):729–737. doi:10.1016/j.molimm.2008.10.016
   PubMed Web of Science ®Google Scholar
• Chen L, Bao B, Wang N, Xie J, Wu W. Oral administration of shark type II collagen suppresses complete Freund's adjuvant-induced rheumatoid arthritis in rats. Pharmaceuticals (Basel)). 2012;5(4):339–352. doi:10.3390/ph5040339
   PubMedGoogle Scholar
• Yasufuku K, Heidler KM, O'Donnell PW, Smith GN, Cummings OW, Foresman BH, Fujisawa T, Wilkes DS. Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol. 2001;25(1):26–34. doi:10.1165/ajrcmb.25.1.4431
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhu C, Ming Z, Cao J, Yan Y, Zhao P, Pang G, Deng Z, Yao Y, Chen Q, et al. Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis. PLoS One. 2017;12(7):e0181075. doi:10.1371/journal.pone.0181075
   PubMed Web of Science ®Google Scholar
• Benito-Ruiz P, Camacho-Zambrano MM, Carrillo-Arcentales JN, Mestanza-Peralta MA, Vallejo-Flores CA, Vargas-López SV, Villacís-Tamayo RA, Zurita-Gavilanes LA. A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort. Int J Food Sci Nutr. 2009;60(Suppl 2):99–113. doi:10.1080/09637480802498820
   PubMed Web of Science ®Google Scholar
• Trc T, Bohmova J. Efficacy and tolerance of enzymatic hydrolysed collagen (EHC) vs. glucosamine sulphate (GS) in the treatment of knee osteoarthritis (KOA). Int Orthop. 2011;35:341–348. doi:10.1007/s00264-010-1010-z
   PubMed Web of Science ®Google Scholar
• Bruyère O, Zegels B, Leonori L, Rabenda V, Janssen A, Bourges C, Reginster J-Y. Effect of collagen hydrolysate in articular pain: a 6-month randomized, double-blind, placebo controlled study. Complement Ther Med. 2012;20(3):124–130. doi:10.1016/j.ctim.2011.12.007
   PubMed Web of Science ®Google Scholar
• Schauss AG, Stenehjem J, Park J, Endres JR, Clewell A. Effect of the novel low molecular weight hydrolyzed chicken sternal cartilage extract, BioCell Collagen, on improving osteoarthritis-related symptoms: a randomized, double-blind, placebo-controlled trial. J Agric Food Chem. 2012;60(16):4096–4101. doi:10.1021/jf205295u
   PubMed Web of Science ®Google Scholar
• Kumar S, Sugihara F, Suzuki K, Inoue N, Venkateswarathirukumara S. A double-blind, placebo-controlled, randomised, clinical study on the effectiveness of collagen peptide on osteoarthritis. J Sci Food Agric. 2015;95(4):702–707. doi:10.1002/jsfa.6752
   PubMed Web of Science ®Google Scholar
• Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016;15:14. doi:10.1186/s12937-016-0130-8
   PubMed Web of Science ®Google Scholar
• Wigren M, Björkbacka H, Andersson L, Ljungcrantz I, Fredrikson GN, Persson M, Bryngelsson C, Hedblad B, Nilsson J. Low levels of circulating CD4 + FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol. 2012;32(8):2000–2004. doi:10.1161/atvbaha.112.251579
   PubMed Web of Science ®Google Scholar
• Roduit C, Frei R, Depner M, Schaub B, Loss G, Genuneit J, Pfefferle P, Hyvärinen A, Karvonen AM, Riedler J, et al. Increased food diversity in the first year of life is inversely associated with allergic diseases. J Allergy Clin Immunol. 2014;133(4):1056–1064. doi:10.1016/j.jaci.2013.12.1044
   PubMed Web of Science ®Google Scholar
• Barth SD, Kaaks R, Johnson T, Katzke V, Gellhaus K, Schulze JJ, Olek S, Kühn T. The ratio of regulatory (FOXP3+) to total (CD3+) T cells determined by epigenetic cell counting and cardiovascular disease risk: a prospective case-cohort study in non-diabetics. EBioMedicine. 2016;11:151–156. doi:10.1016/j.ebiom.2016.07.035
   PubMed Web of Science ®Google Scholar
• Intlekofer AM, Thompson CB. At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy. J Leukoc Biol. 2013;94(1):25–39. doi:10.1189/jlb.1212621
   PubMed Web of Science ®Google Scholar
• Schmidt-Weber CB, Blaser K. The role of TGF-beta in allergic inflammation. Immunol Allergy Clin North Am. 2006;26(2):233–244. doi:10.1016/j.iac.2006.02.011
   PubMed Web of Science ®Google Scholar
• Tirado-Rodriguez B, Ortega E, Segura-Medina P, Huerta-Yepez S. TGF-β: an important mediator of allergic disease and a molecule with dual activity in cancer development. J Immunol Res. 2014;2014:1–15. doi:10.1155/2014/318481
   Web of Science ®Google Scholar
• Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, et al. A critical role for eosinophils in allergic airways remodeling. Science. 2004;305(5691):1776–1779. doi:10.1126/science.1100283
   PubMed Web of Science ®Google Scholar
• Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, Howarth PH. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1997;156(2 Pt 1):642–647. doi:10.1164/ajrccm.156.2.9605065
   PubMed Web of Science ®Google Scholar
• Jago CB, Yates J, Câmara NOS, Lechler RI, Lombardi G. Differential expression of CTLA-4 among T cell subsets. Clin Exp Immunol. 2004;136(3):463–471. doi:10.1111/j.1365-2249.2004.02478.x
   PubMed Web of Science ®Google Scholar
• Huang J-H, Tykocinski ML. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells. Int Immunol. 2001;13(4):529–539. doi:10.1093/intimm/13.4.529
   PubMed Web of Science ®Google Scholar
• Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH. CTLA-4 regulates induction of anergy in vivo. Immunity. 2001;14(2):145–155. doi:10.1016/s1074-7613(01)00097-8
   PubMed Web of Science ®Google Scholar
• Xu GL, Zhu XH, Guo B, Wu YZ. Involvement of CTLA-4 in T-cell anergy induced by staphylococcal enterotoxin A in vitro. Mol Immunol. 2004;41(1):1–8. doi:10.1016/j.molimm.2004.03.001
   PubMed Web of Science ®Google Scholar
• Schwartz RH. T cell anergy. Annu Rev Immunol. 2003;21:305–334. doi:10.1146/annurev.immunol.21.120601.141110
   PubMed Web of Science ®Google Scholar
• Edgar S, Hopley B, Genovese L, Sibilla S, Laight D, Shute J. Effects of collagen-derived bioactive peptides and natural antioxidant compounds on proliferation and matrix protein synthesis by cultured normal human dermal fibroblasts. Sci Rep. 2018;8(1):10474. doi:10.1038/s41598-018-28492-w
   PubMed Web of Science ®Google Scholar
• Orlowsky EW, Kraus VB. The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol. 2015;42(3):363–371. doi:10.3899/jrheum.140382
   PubMed Web of Science ®Google Scholar
• Mobasheri A. The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep. 2013;15(12):385. doi:10.1007/s11926-013-0385-4
   PubMed Web of Science ®Google Scholar
• Kalchishkova N, Furst CM, Heinegard D, Blom AM. NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H. J Biol Chem. 2011;286(32):27915–27926. doi:10.1074/jbc.M111.242834
   PubMed Web of Science ®Google Scholar
• Sjoberg A, Onnerfjord P, Morgelin M, Heinegard D, Blom AM. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem. 2005;280(37):32301–32308. doi:10.1074/jbc.M504828200
   PubMed Web of Science ®Google Scholar
• Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem. 2001;276(13):10229–10233. doi:10.1074/jbc.M100099200
   PubMed Web of Science ®Google Scholar
• Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM, et al. Identification of a central role for complement in osteoarthritis. Nat Med. 2011;17(12):1674–1679. doi:10.1038/nm.2543
   PubMed Web of Science ®Google Scholar
• Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil. 2013;21(1):16–21. doi:10.1016/j.joca.2012.11.012
   PubMed Web of Science ®Google Scholar
• Fathollahi A, Aslani S, Jamshidi A, Mahmoudi M. Epigenetics in osteoarthritis: novel spotlight. J Cell Physiol. 2019;234(8):12309–12324. doi:10.1002/jcp.28020
   PubMed Web of Science ®Google Scholar
• Marcu KB, Otero M, Olivotto E, Borzi RM, Goldring MB. NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets. 2010;11(5):599–613. doi:10.2174/138945010791011938
   PubMed Web of Science ®Google Scholar
• Quintieri L, Monaci L, Baruzzi F, Giuffrida MG, de Candia S, Caputo L. Reduction of whey protein concentrate antigenicity by using a combined enzymatic digestion and ultrafiltration approach. J Food Sci Technol. 2017;54(7):1910–1916. doi:10.1007/s13197-017-2625-5
   PubMed Web of Science ®Google Scholar
• Haspeslagh E, Heyndrickx I, Hammad H, Lambrecht BN. The hygiene hypothesis: immunological mechanisms of airway tolerance. Curr Opin Immunol. 2018;54:102–108. doi:10.1016/j.coi.2018.06.007
   PubMed Web of Science ®Google Scholar
• Duan W, Croft M. Control of regulatory T cells and airway tolerance by lung macrophages and dendritic cells. Ann Am Thorac Soc. 2014;11(Suppl 5):S306–S313. doi:10.1513/AnnalsATS.201401-028AW
   PubMedGoogle Scholar
• Kamdem JP, Tsopmo A. Reactivity of peptides within the food matrix. J Food Biochem. 2019;43(1):e12489. doi:10.1111/jfbc.12489
   PubMed Web of Science ®Google Scholar
• Tayyem RF, Bawadi HA, Shehadah IN, Abu-Mweis SS, Agraib LM, Bani-Hani KE, Al-Jaberi T, Al-Nusairr M, Heath DD. Macro- and micronutrients consumption and the risk for colorectal cancer among Jordanians. Nutrients. 2015;7(3):1769–1786. doi:10.3390/nu7031769
   PubMed Web of Science ®Google Scholar
• Slattery ML, Potter JD, Sorenson AW. Age and risk factors for colon cancer (United States and Australia): are there implications for understanding differences in case-control and cohort studies? Cancer Causes Control. 1994;5(6):557–563. doi:10.1007/BF01831384
   PubMed Web of Science ®Google Scholar
• Slattery ML, Caan BJ, Potter JD, Berry TD, Coates A, Duncan D, Edwards SL. Dietary energy sources and colon cancer risk. Am J Epidemiol. 1997;145(3):199–210. doi:10.1093/oxfordjournals.aje.a009092
   PubMed Web of Science ®Google Scholar
• Fernandez E, Negri E, La Vecchia C, Franceschi S. Diet diversity and colorectal cancer. Prev Med. 2000;31(1):11–14. doi:10.1006/pmed.2000.0667
   PubMed Web of Science ®Google Scholar
• Slattery ML, Berry TD, Potter J, Caan B. Diet diversity, diet composition, and risk of colon cancer (United States). Cancer Causes Control. 1997;8(6):872–882. doi:10.1023/a:1018416412906
   PubMed Web of Science ®Google Scholar
• Su L-y, Shi Y-x, Yan M-r, Xi Y, Su X-l. Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway. Acta Pharmacol Sin. 2015;36(12):1514–1519. doi:10.1038/aps.2015.80
   PubMed Web of Science ®Google Scholar
• Suarez-Jimenez G-M, Burgos-Hernandez A, Ezquerra-Brauer J-M. Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals. Mar Drugs. 2012;10(5):963–986. doi:10.3390/md10050963
   PubMed Web of Science ®Google Scholar
• Corthay A. Does the immune system naturally protect against cancer? Front Immunol. 2014;5:197. doi:10.3389/fimmu.2014.00197
   PubMed Web of Science ®Google Scholar
• Barati M, Yousefi M, Ebrahimi-Mameghani M, Mohammadi H, Brazvan B, Nickho H, Fouladi M, Mohammadi M. Oryzatensin-stimulated PBMCs increase cancer progression in-vitro. Iran J Allergy Asthma Immunol. 2017;16(2):120–126.
   PubMed Web of Science ®Google Scholar
• Luo Q, Boom RM, Janssen AEM. Digestion of protein and protein gels in simulated gastric environment. LWT - Food Sci Technol. 2015;63(1):161–168. doi:10.1016/j.lwt.2015.03.087
   Web of Science ®Google Scholar
• Ruiz GA, Opazo-Navarrete M, Meurs M, Minor M, Sala G, van Boekel M, Stieger M, Janssen AEM. Denaturation and in vitro gastric digestion of heat-treated quinoa protein isolates obtained at various extraction pH. Food Biophys. 2016;11:184–197. doi:10.1007/s11483-016-9429-4
   PubMed Web of Science ®Google Scholar